Crit Care Explor · 2024
Methylene Blue in Septic Shock: A Systematic Review and Meta-AnalysisConclusion: Among critically ill adults with septic shock, based on low-certainty evidence, MB may reduce short-term mortality, duration of vasopressors, and hospital length of stay, with no evidence of increased adverse events. Rigorous randomized trials evaluating the efficacy of MB in septic shock are needed.